Page 50 - Read Online

cells. Carcinogenesis 2011;32:1697-705. 2010;11 Suppl 4:S25.
17. Stan SD, Hahm ER, Warin R, Singh SV. Withaferin A causes 30. Zhao BC, Wang ZJ, Mao WZ, Ma HC, Han JG, Zhao B, Xu HM.
FOXO3a- and Bim-dependent apoptosis and inhibits growth of CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric
human breast cancer cells in vivo. Cancer Res 2008;68:7661-9. carcinoma. World J Gastroenterol 2011;17:2389-929.
18. Bargagna-Mohan P, Hamza A, Kim YE, Khuan Abby Ho Y, Mor- 31. Lee HJ, Kim SW, Kim HY, Li S, Yun HJ, Song KS, Kim S, Jo DY.
Vaknin N, Wendschlag N, Liu J, Evans RM, Markovitz DM, Zhan Chemokine receptor CXCR4 expression, function, and clinical
CG, Kim KB, Mohan R. The tumor inhibitor and antiangiogenic implications in gastric cancer. Int J Oncol 2009;34:473-80.
agent withaferin A targets the intermediate filament protein vimentin. 32. Wang J, Guan E, Roderiquez G, Calvert V, Alvarez R, Norcross MA.
Chem Biol 2007;14:623-34. Role of tyrosine phosphorylation in ligand-independent sequestration
19. Kakar SS, Ratajczak MZ, Powell KS, Moghadamfalahis M, Miller of CXCR4 in human primary monocytes-macrophages. J Biol Chem
DM. Withaferin A alone and in combination with cisplatin suppresses 2001;276:49236-43.
growth and metastasis of ovarian cancer by targeting putative cancer 33. Vila-Coro AJ, Rodríguez-Frade JM, Martín De Ana A, Moreno-Ortíz
stem cells. PLoS One 2014;9:e10756. MC, Martínez AC, Mellado M. The chemokine SDF-1alpha triggers
20. Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool CXCR4 receptor dimerization and activates the JAK/STAT pathway.
K, Tang DG. Side population is enriched in tumorigenic, stem- FASEB J 1999;13:1699-710.
like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are 34. Ahr B, Denizot M, Robert-Hebmann V, Brelot A, Biard-Piechaczyk
similarly tumorigenic. Cancer Res 2005;65:6207-19. M. Identification of the cytoplasmic domains of CXCR4 involved in
21. Yang Y, Fan Y, Qi Y, Liu D, Wu K, Wen F, Zhao S. Side population Jak2 and STAT3 phosphorylation. J Biol Chem 2005;280:6692-700.
cells separated from A549 lung cancer cell line possess cancer stem 35. Bromberg JF, Darnell JE Jr. Potential roles of Stat1 and Stat3
cell-like properties and inhibition of autophagy potentiates the in cellular transformation. Cold Spring Harb Symp Quant Biol
cytotoxic effect of cisplatin. Oncol Rep 2015;34:929-35. 1999;64:425-8.
22. Kang NY, Yun SW, Ha HH, Park SJ, Chang YT. Embryonic and 36. Bromberg JE, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell Y,
induced pluripotent stem cell staining and sorting with the live-cell Albanese C, Darnell JE Jr. Stat3 as an oncogene. Cell 1999;89:295-
fluorescence imaging probe CDy1. Nat Protoc 2011;6:1044-52. 303.
23. Zhang I, Yeger H, Das B, Irwin MS, Baruchel S. Tissue 37. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang
microenvironment modulates CXCR4 expression and tumor S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J,
metastasis in neuroblastoma. Neoplasia 2007;9:36-46. Bromberg J, Pardoll D, Jove R, Yu H. Constitutive Stat3 activity
24. Zhou J, Wulfkuhle J, Zhang H, Gu P, Yang Y, Deng J, Margolick JB, up-regulates VEGF expression and tumor angiogenesis. Oncogene
Liotta LA, Petricoin E 3rd, Zhang Y. Activation of the PTEN/mTOR/ 2002;21:2000-8.
STAT3 pathway in breast cancer stem-like cells is required for 38. Zhang XW, Audet J, Piret JM, Li YX. Cell cycle distribution of
viability and maintenance. Proc Natl Acad Sci U S A 2007;104:16158- primitive haematopoietic cells stimulated in vitro and in vivo. Cell
63. Prolif 2001;34:321-30.
25. Li HD, Huang C, Huang KJ, Wu WD, Jiang T, Cao J, Feng ZZ, Qiu 39. Pfeiffer M, Hartmann TN, Leick M, Catusse J, Schmitt-Graeff
ZJ. STAT3 knockdown reduces pancreatic cancer cell invasiveness A, Burger M. Alternative implication of CXCR4 in JAK2/STAT3
and matrix metalloproteinase-7 expression in nude mice. PLoS One activation in small cell lung cancer. Br J Cancer 2009;100:1949-56.
2011;6:e25941. 40. Maroni P, Bendinelli P, Matteucci E, Desiderio MA. HGF induces
26. Zao Y, Yan Q, Long X, Chen X, Wang Y. Vimentin affects mobility CXCR4 and CXCL12-mediated tumor invasion through Ets1 and
and invasiveness of prostate cancer cells. Cancer Biochem Funct NF-kB. Carcinogenesis 2007;28:267-79.
2008;26:571-7. 41. Struchmann K, Mertz K, Steu S, Storz M, Staller P, Krek W, Schraml
27. Mitra A. Cell surface vimentin (CSV) redefines CTCs to monitor P, Moch H. pVHL co-ordinately regulates CXCR4/ CCXCL12 and
cancer progression in patients. J Cancer Prev Curr Res 2014;1:00014. MMP2/MMP9 expression in human clear cell renal cell acrcinoma. J
28. Velasco-Vlaquez MA, Popov VM, Lisanti MP, Pestell RG. The role Pathol 2008;214:464-71.
of breast cancer stem cells in metastasis and therapeutic implications. 42. Yu H, Kortylewski M, Pardoll D. Crosstalk between cancer and
Am J Pathol 2011;179:2-11. immune cells: role of STAT3 in the tumour microenvironment. Nat
29. Grover A, Shandilya A, Punetha A, Bisaria VS, Sundar D. Inhibition Rev Immunol 2007;7:41-51.
of the NEMO/IKKß association complex formation, a novel 43. Vermeulen L, de Sousa e Melo F, Richel DJ, Medema JP. The
mechanism associated with the NF-κB activation suppression by developing cancer stem-cell model: clinical challenges and
Withania somnifera’s key metabolite withaferin A. BMC Genomics opportunities. Lancet Oncol 2012;13:e83-9.

40
Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ Issue 1 ¦ January 15, 2016 ¦